OOIR: Observatory of International Research

Papers

(The H4-Index of Current Medicinal Chemistry is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Corrigendum to: Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches	104
Challenges of Natural Anticancer and Anti-inflammatory Agents	90
Identification of Critical Genes Related to Breast Cancer with Brain Metastasis Through Bioinformatics Analysis	72
Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review	58
Construction and Biological Evaluation of Different Nanoshell Thickness Ni@SiO₂ Nanotubes as Good Protein Separation Carriers for Bovine Hemoglobin	56
Ferroptosis Inducers for Prostate Cancer Therapy	53
Integrated Exploration of Pyranocoumarin Derivatives as Synergistic Inhibitors of Dual-target for Mpro and PLpro Proteins of SARS-CoV- 2 through Molecular Docking, ADMET Analysis, and Molecular Dynami	52
Intermittent Fasting and Fasting-mimicking Diet: Promising Strategies in Cancer Management	51
Developing Generalizable Scoring Functions for Molecular Docking: Challenges and Perspectives	50
Integrating Transcriptomic Data and Mendelian RandomizationAnalyses Reveals Potentially Novel Sepsis-related Targets	49
An Updated Review Deciphering Apigenin Nanostructures as Promising Therapeutic Efficiency in Human Carcinomas	49
Detection of Prostate Cancer Biomarker PCA3 by Using Aptasensors	47
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile?	46
Drug-Resistant Infections: A Global Challenge for the Future	43
Paneth Cells: Recent Updates on Elucidating Therapeutic Implications in Gastroenterological Disease Management	43
ANGPTL4-the Link Binding Lipid Metabolism and Inflammation	42
Commentary on the Role of Medicinal Cannabis in Healthy Aging and Neuroprotection	40
Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers	40
Potential for Novel Therapeutic Uses of Alpha Lipoic Acid	40
The Effects of Curcumin on Brain-Derived Neurotrophic Factor Expression in Neurodegenerative Disorders	39
Long Non-coding RNA SNHG16 Facilitates Esophageal Cancer Cell Proliferation and Self-renewal through the microRNA-802/PTCH1 Axis	37
Chalcogenium-AZT Derivatives: A Plausible Strategy To Tackle The RT-Inhibitors-Related Oxidative Stress While Maintaining Their Anti- HIV Properties	37
Mitochondrial DNA Mutations in Colorectal Cancer Stem Cells: Implications for Tumor Dynamics and Therapeutic Strategies	36
Intimal Macrovascular Pericytes: Their Role in Vascular Biology and Atherogenesis	36
Research Prospects for the Mitochondria in Glaucoma: A Bibliometric Analysis	36

MEF2C is a Potential Prognostic Biomarker and is Correlated with Immune Infiltrates in Lung Adenocarcinoma	36
Expression of TCEAL2 is a Novel Prognostic Biomarker and Potential Therapeutic Target in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	35
Clinical Application and Synthesis Methods of Deuterated Drugs	34
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2	34
Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy	33
New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment	33
Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer	32
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder	32
Neuroinflammatory Human Brain Organoids Enable Comprehensive Drug Screening Studies: Fingolimod and its Analogues in Focus	32
Exploring the Anticancer Potential of Astragalin in Triple Negative Breast Cancer Cells by Attenuating Glycolytic Pathway through AMPK/mTOR	32